Fortrea Holdings Inc.
- FTRE
- NASDAQ
- Biotechnology
- Clinical Research (CRO)
- Biopharmaceutical Development
$22.63
Today +0.63%Quote Oct 19, 2026, 06:40 PM UTC
+10.90%over the last month
Max drawdown −5.0%From 1-month high −1.1%3 months +26.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Fortrea
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
14,000
Founded
2023
Market value
$2.15B
Quote Oct 19
Floor
$21.38
5.5% below price
Resistance
$22.97
1.5% above price
Price vs analyst targets
12 analysts
Lowest target
$16.00Highest target
$25.00
$16.00Highest target
$25.00
- Price $22.63
- Average target $21.33
- Analysts' target range
Analysts' average target sits about 6% lower.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about FTREPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free